Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.

Conway K, Edmiston SN, Parker JS, Kuan PF, Tsai YH, Groben PA, Zedek DC, Scott GA, Parrish EA, Hao H, Pearlstein MV, Frank JS, Carson CC, Wilkerson MD, Zhao X, Slater NA, Moschos SJ, Ollila DW, Thomas NE.

J Invest Dermatol. 2019 Jun;139(6):1349-1361. doi: 10.1016/j.jid.2018.11.024. Epub 2018 Dec 6.

PMID:
30529013
2.

Infection Retardant Coatings Impact on Bacterial Presence in Penile Prosthesis Surgery: A Multicenter Study.

Jani K, Smith C, Delk JR 2nd, Carson CC, Donatucci CF, Cleves MA, Wilson SK, Henry GD.

Urology. 2018 Sep;119:104-108. doi: 10.1016/j.urology.2018.05.028. Epub 2018 Jun 9.

PMID:
29894775
3.

Readability, credibility and quality of patient information for hypogonadism and testosterone replacement therapy on the Internet.

McBride JA, Carson CC, Coward RM.

Int J Impot Res. 2017 May;29(3):110-114. doi: 10.1038/ijir.2017.4. Epub 2017 Feb 23.

PMID:
28228646
4.

Editorial Comment.

Carson CC 3rd.

J Urol. 2017 Feb;197(2):458. doi: 10.1016/j.juro.2016.08.139. Epub 2016 Nov 3. No abstract available.

PMID:
27818154
5.

Editorial Comment.

Carson CC.

Urology. 2016 Sep;95:44. doi: 10.1016/j.urology.2016.03.064. Epub 2016 Jul 9. No abstract available.

PMID:
27401714
6.

Adult-Onset Hypogonadism.

Khera M, Broderick GA, Carson CC 3rd, Dobs AS, Faraday MM, Goldstein I, Hakim LS, Hellstrom WJ, Kacker R, Köhler TS, Mills JN, Miner M, Sadeghi-Nejad H, Seftel AD, Sharlip ID, Winters SJ, Burnett AL.

Mayo Clin Proc. 2016 Jul;91(7):908-26. doi: 10.1016/j.mayocp.2016.04.022. Epub 2016 Jun 21. Review.

7.

The Availability and Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet.

McBride JA, Carson CC 3rd, Coward RM.

Am J Mens Health. 2018 Sep;12(5):1352-1357. doi: 10.1177/1557988316648704. Epub 2016 May 11.

8.

Testosterone deficiency in the aging male.

McBride JA, Carson CC 3rd, Coward RM.

Ther Adv Urol. 2016 Feb;8(1):47-60. doi: 10.1177/1756287215612961. Review.

9.

Prostate Cancer and Testosterone Replacement Therapy--What is the Risk?

Carson CC 3rd, Kirby R.

J Urol. 2015 Dec;194(6):1527-8. doi: 10.1016/j.juro.2015.09.059. Epub 2015 Sep 18. No abstract available.

PMID:
26386278
10.

Special considerations for placement of an inflatable penile prosthesis for the patient with Peyronie's disease: techniques and patient preference.

Lyons MD, Carson CC 3rd, Coward RM.

Med Devices (Auckl). 2015 Jul 27;8:331-40. doi: 10.2147/MDER.S57252. eCollection 2015. Review.

11.

Tramadol for the management of premature ejaculation: a timely systematic review.

Kirby EW, Carson CC, Coward RM.

Int J Impot Res. 2015 Jul;27(4):121-7. doi: 10.1038/ijir.2015.7. Epub 2015 May 14. Review.

PMID:
25971856
12.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, Alldredge VD, Parrish E, Hanna SC, Berkowitz P, Rubenstein DS, Miller CR, Bear JE, Ollila DW, Sharpless NE, Conway K, Thomas NE.

Clin Cancer Res. 2015 May 1;21(9):2167-76. doi: 10.1158/1078-0432.CCR-14-1826.

13.

Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).

Carson CC 3rd, Sadeghi-Nejad H, Tursi JP, Smith TM, Kaufman GJ, Gilbert K, Honig SC.

BJU Int. 2015 Nov;116(5):815-22. doi: 10.1111/bju.13120. Epub 2015 May 13.

14.

Low testosterone has a similar prevalence among men with sexual dysfunction due to either Peyronie's disease or erectile dysfunction and does not correlate with Peyronie's disease severity.

Kirby EW, Verges D, Matthews J, Carson CC, Coward RM.

J Sex Med. 2015 Mar;12(3):690-6. doi: 10.1111/jsm.12805. Epub 2015 Jan 8.

PMID:
25580982
15.

Diagnosis and management of testosterone deficiency.

McBride JA, Carson CC, Coward RM.

Asian J Androl. 2015 Mar-Apr;17(2):177-86. doi: 10.4103/1008-682X.143317. Review.

16.

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

Thomas NE, Slater NA, Edmiston SN, Zhou X, Kuan PF, Groben PA, Carson CC, Hao H, Parrish E, Moschos SJ, Berwick M, Ollila DW, Conway K.

Pigment Cell Melanoma Res. 2014 Nov;27(6):1097-105. doi: 10.1111/pcmr.12289. Epub 2014 Jul 14.

17.

Peyronie's disease: review and recent advances.

Langston JP, Carson CC 3rd.

Maturitas. 2014 Aug;78(4):341-3. doi: 10.1016/j.maturitas.2014.05.024. Epub 2014 Jun 6. Review.

PMID:
24984940
18.

Controversies in the treatment of male hypogonadism.

Carson CC 3rd, Khera M.

Urology. 2014 Apr;83(4):957. doi: 10.1016/j.urology.2014.01.002. No abstract available.

PMID:
24680460
19.

Testosterone Supplementation in Hypogonadal Men on 5-ARI Therapy.

Nickel JC, Carson CC.

Sex Med Rev. 2014 Apr;2(2):75-78. doi: 10.1002/smrj.27. Epub 2015 Oct 19. Review.

PMID:
27784592
20.

Deep Venous Thrombosis as a Complication of Reservoir Placement in Post-Prostatectomy Erectile Dysfunction and Urinary Incontinence Prosthetic Surgery.

Selph JP, McKim SE, Langston JP, Carson CC.

Sex Med Rev. 2014 Apr;2(2):59-63. doi: 10.1002/smrj.28. Epub 2015 Oct 19. Review.

PMID:
27784590
21.

Government Regulation Can Be Helpful.

Carson CC.

Sex Med Rev. 2014 Apr;2(2):57-58. doi: 10.1002/smrj.22. Epub 2015 Oct 19. No abstract available.

PMID:
27784589
22.

Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.

Jeck WR, Parker J, Carson CC, Shields JM, Sambade MJ, Peters EC, Burd CE, Thomas NE, Chiang DY, Liu W, Eberhard DA, Ollila D, Grilley-Olson J, Moschos S, Neil Hayes D, Sharpless NE.

Pigment Cell Melanoma Res. 2014 Jul;27(4):653-63. doi: 10.1111/pcmr.12238. Epub 2014 Apr 7.

23.

Mechanisms of chromosomal instability in melanoma.

Kaufmann WK, Carson CC, Omolo B, Filgo AJ, Sambade MJ, Simpson DA, Shields JM, Ibrahim JG, Thomas NE.

Environ Mol Mutagen. 2014 Jul;55(6):457-71. doi: 10.1002/em.21859. Epub 2014 Feb 24.

24.

Minimally invasive treatment of Peyronie's disease: evidence-based progress.

Jordan GH, Carson CC, Lipshultz LI.

BJU Int. 2014 Jul;114(1):16-24. doi: 10.1111/bju.12634. Review.

25.

Tadalafil - a therapeutic option in the management of BPH-LUTS.

Carson CC, Rosenberg M, Kissel J, Wong DG.

Int J Clin Pract. 2014 Jan;68(1):94-103. doi: 10.1111/ijcp.12305. Review.

PMID:
24341303
26.

Outcomes of surgical treatment of Peyronie's disease.

Carson CC, Levine LA.

BJU Int. 2014 May;113(5):704-13. doi: 10.1111/bju.12565.

27.

Testosterone Replacement Therapy in Men with Prostate Cancer: What Is the Evidence?

Patrick Selph J, Carson CC.

Sex Med Rev. 2013 Oct;1(3):135-142. doi: 10.1002/smrj.15. Epub 2015 Oct 19. Review.

PMID:
27784552
28.

Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons.

Ferguson JE 3rd, Carson CC 3rd.

Arab J Urol. 2013 Sep;11(3):222-9. doi: 10.1016/j.aju.2013.07.009. Epub 2013 Sep 18. Review.

29.

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

Jackson G, Nehra A, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham G, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis JB, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC.

Int J Clin Pract. 2013 Nov;67(11):1163-72. doi: 10.1111/ijcp.12200. Epub 2013 May 28. Review.

PMID:
23714173
30.

Why Sexual Medicine Reviews?

Carson CC.

Sex Med Rev. 2013 May;1(1):1-2. doi: 10.1002/smrj.6. Epub 2015 Oct 21. No abstract available.

PMID:
27784555
31.

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

Schlegel J, Sambade MJ, Sather S, Moschos SJ, Tan AC, Winges A, DeRyckere D, Carson CC, Trembath DG, Tentler JJ, Eckhardt SG, Kuan PF, Hamilton RL, Duncan LM, Miller CR, Nikolaishvili-Feinberg N, Midkiff BR, Liu J, Zhang W, Yang C, Wang X, Frye SV, Earp HS, Shields JM, Graham DK.

J Clin Invest. 2013 May;123(5):2257-67. doi: 10.1172/JCI67816. Epub 2013 Apr 15.

32.

Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.

Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, Jones N, Kaufman GJ, Carson CC 3rd.

J Urol. 2013 Jul;190(1):199-207. doi: 10.1016/j.juro.2013.01.087. Epub 2013 Jan 31. Review.

PMID:
23376148
33.

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk.

Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen RC, Sadovsky R, Seftel AD, Vlachopoulos C, Wu FC.

J Urol. 2013 Jun;189(6):2031-8. doi: 10.1016/j.juro.2012.12.107. Epub 2013 Jan 9. Review.

PMID:
23313195
34.

Words of wisdom. Re: Complex artificial urinary sphincter revision and reimplantation cases--how do they fare compared to virgin cases?

Carson CC.

Eur Urol. 2012 Dec;62(6):1199-200. doi: 10.1016/j.eururo.2012.09.020. No abstract available.

PMID:
23141129
35.

Comment on: Drolet BC, Christopher DA, Fischer SA. Residents' response to duty-hour regulations--a follow-up national survey. N Engl J Med 2012;366:1657-1659.

Carson CC 3rd.

Urology. 2012 Nov;80(5):969-70. doi: 10.1016/j.urology.2012.07.041. Epub 2012 Sep 19. No abstract available.

PMID:
22999454
36.

The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.

Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Ganz P, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC.

Mayo Clin Proc. 2012 Aug;87(8):766-78. doi: 10.1016/j.mayocp.2012.06.015.

37.

Long-term infection outcomes of 3-piece antibiotic impregnated penile prostheses used in replacement implant surgery.

Nehra A, Carson CC 3rd, Chapin AK, Ginkel AM.

J Urol. 2012 Sep;188(3):899-903. doi: 10.1016/j.juro.2012.04.116. Epub 2012 Jul 20.

PMID:
22819402
38.

Dorsal penile nerve block prior to inflatable penile prosthesis placement: a randomized, placebo-controlled trial.

Raynor MC, Smith A, Vyas SN, Selph JP, Carson CC 3rd.

J Sex Med. 2012 Nov;9(11):2975-9. doi: 10.1111/j.1743-6109.2012.02756.x. Epub 2012 May 29.

PMID:
22642415
39.

An outcomes analysis of over 200 revision surgeries for penile prosthesis implantation: a multicenter study.

Henry GD, Donatucci CF, Conners W, Greenfield JM, Carson CC, Wilson SK, Delk J, Lentz AC, Cleves MA, Jennermann CJ, Kramer AC.

J Sex Med. 2012 Jan;9(1):309-15. doi: 10.1111/j.1743-6109.2011.02524.x. Epub 2011 Nov 14.

PMID:
22082149
40.

Postprostatectomy erectile dysfunction: the role of penile rehabilitation.

Defade BP, Carson CC 3rd, Kennelly MJ.

Rev Urol. 2011;13(1):6-13.

41.

Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.

Carson CC 3rd, Rosano G.

J Sex Med. 2012 Jan;9(1):54-67. doi: 10.1111/j.1743-6109.2011.02337.x. Epub 2011 Jun 15. Review.

PMID:
21676183
42.

Penile prosthesis infection: approaches to prevention and treatment.

Selph JP, Carson CC 3rd.

Urol Clin North Am. 2011 May;38(2):227-35. doi: 10.1016/j.ucl.2011.02.007. Review.

PMID:
21621089
43.

Peyronie disease: plication or grafting.

Langston JP, Carson CC 3rd.

Urol Clin North Am. 2011 May;38(2):207-16. doi: 10.1016/j.ucl.2011.03.001. Review.

PMID:
21621087
44.

The urologic clinics of North America. Erectile dysfunction.

Carson CC 3rd.

Urol Clin North Am. 2011 May;38(2):xi. doi: 10.1016/j.ucl.2011.02.008. No abstract available.

PMID:
21621075
45.

Editorial comment. YouTube as a source of information on kidney stone disease.

Carson CC.

Urology. 2011 Mar;77(3):562-3; author reply 563. doi: 10.1016/j.urology.2010.08.046. No abstract available.

PMID:
21377003
46.

Long-term infection rates in diabetic patients implanted with antibiotic-impregnated versus nonimpregnated inflatable penile prostheses: 7-year outcomes.

Mulcahy JJ, Carson CC 3rd.

Eur Urol. 2011 Jul;60(1):167-72. doi: 10.1016/j.eururo.2011.01.046. Epub 2011 Feb 4.

PMID:
21316145
47.
48.

Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup.

Carson CC 3rd, Mulcahy JJ, Harsch MR.

J Urol. 2011 Feb;185(2):614-8. doi: 10.1016/j.juro.2010.09.094. Epub 2010 Dec 18.

PMID:
21168870
49.

Urinary infections in men.

Raynor MC, Carson CC 3rd.

Med Clin North Am. 2011 Jan;95(1):43-54. doi: 10.1016/j.mcna.2010.08.015. Review.

PMID:
21095410
50.

AMS 700 inflatable penile prosthesis with InhibiZone.

McKim SE, Carson CC 3rd.

Expert Rev Med Devices. 2010 May;7(3):311-7. doi: 10.1586/erd.10.6.

PMID:
20420554

Supplemental Content

Loading ...
Support Center